Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables
Disease | Case Count | Rate |
---|---|---|
Anthrax | 1 | 0.00 |
Arboviral diseases | ||
Chikungunya virus disease | 37 | 0.01 |
Eastern equine encephalitis virus disease | ||
Neuroinvasive | 13 | 0.00 |
Non-neuroinvasive | — | — |
Jamestown Canyon virus disease | ||
Neuroinvasive | 10 | 0.00 |
Non-neuroinvasive | 3 | 0.00 |
La Crosse virus disease | ||
Neuroinvasive | 84 | 0.03 |
Non-neuroinvasive | 4 | 0.00 |
Powassan virus disease | ||
Neuroinvasive | 19 | 0.01 |
Non-neuroinvasive | 1 | 0.00 |
St. Louis encephalitis virus disease | ||
Neuroinvasive | 14 | 0.00 |
Non-neuroinvasive | 2 | 0.00 |
West Nile virus disease | ||
Neuroinvasive | 558 | 0.17 |
Non-neuroinvasive | 172 | 0.05 |
Western equine encephalitis virus disease | ||
Neuroinvasive | — | — |
Non-neuroinvasive | — | — |
Babesiosis | ||
Total | 1,820 | 0.64 |
Confirmed | 1,631 | 0.57 |
Probable | 189 | 0.07 |
Botulism | ||
Total | 189 | 0.06 |
Foodborne | 8 | 0.00 |
Infant | 146 | 3.91 |
Other (wound & unspecified) | 35 | 0.01 |
Brucellosis | 87 | 0.03 |
Campylobacteriosis | 51,764 | 15.71 |
Candida auris, clinical † | 255 | 0.08 |
Carbapenemase-producing carbapenem-resistant Enterobacteriaceae | 1,848 | 0.61 |
Chancroid | — | — |
Chlamydia trachomatis infection | 1,579,837 | 479.49 |
Cholera | 1 | 0.00 |
Coccidioidomycosis | 19,220 | 13.70 |
Coronavirus Disease 2019 (COVID-19) | ||
Total | 21,149,731 | 6,419.04 |
Confirmed | 19,179,356 | 5,821.03 |
Probable § | 1,970,375 | 598.02 |
Cryptosporidiosis | ||
Total | 7,648 | 2.32 |
Confirmed | 5,861 | 1.78 |
Probable | 1,787 | 0.54 |
Cyclosporiasis | 2,689 | 0.90 |
Dengue virus infections ¶ | ||
Dengue | 441 | 0.13 |
Dengue-like illness | 9 | 0.00 |
Severe dengue | — | — |
Diphtheria | 1 | 0.00 |
Ehrlichiosis and Anaplasmosis | ||
Anaplasma phagocytophilum infection | 3,637 | 1.15 |
Ehrlichia chaffeensis infection | 1,178 | 0.37 |
Ehrlichia ewingii infection | 21 | 0.01 |
Undetermined ehrlichiosis/anaplasmosis | 50 | 0.02 |
Giardiasis | 9,453 | 3.66 |
Gonorrhea | 677,751 | 205.70 |
Haemophilus influenzae, invasive disease | ||
All ages, all serotypes | 2,996 | 0.91 |
Age <5 years | ||
Serotype b | 15 | 0.08 |
Non-b serotype | 76 | 0.39 |
Nontypeable | 104 | 0.54 |
Unknown serotype | 121 | 0.04 |
Hansen's disease | 68 | 0.02 |
Hantavirus infection, non-hantavirus pulmonary syndrome ** | 2 | 0.00 |
Hantavirus pulmonary syndrome | 14 | 0.00 |
Hemolytic uremic syndrome post-diarrheal | 167 | 0.05 |
Hepatitis, Viral Disease †† | ||
Hepatitis A | 9,946 | 3.02 |
Hepatitis B | ||
Acute | 2,155 | 0.66 |
Perinatal infection | 10 | 0.13 |
Hepatitis C | ||
Acute | 6,025 | 1.89 |
Confirmed | 4,798 | 1.50 |
Probable | 1,227 | 0.38 |
Perinatal infection | 165 | 1.62 |
Human immunodeficiency virus diagnoses | 25,007 | 7.59 |
Influenza-associated pediatric mortality | 171 | 0.23 |
Invasive pneumococcal disease §§ | ||
All ages | 11,946 | 4.86 |
Confirmed | 11,718 | 4.76 |
Probable | 228 | 0.09 |
Age <5 years | 561 | 0.21 |
Confirmed | 536 | 3.45 |
Probable | 25 | 0.16 |
Legionellosis ¶¶ | 6,310 | 1.92 |
Leptospirosis | 51 | 0.02 |
Listeriosis *** | ||
Total | 780 | 0.24 |
Confirmed | 754 | 0.23 |
Probable | 26 | 0.01 |
Lyme disease | ||
Total | 18,000 | 5.49 |
Confirmed | 12,123 | 3.70 |
Probable | 5,877 | 1.79 |
Malaria | 603 | 0.18 |
Measles ††† | ||
Total | 12 | 0.00 |
Indigenous | 6 | 0.00 |
Imported | 6 | 0.00 |
Meningococcal disease | ||
All serogroups | 242 | 0.07 |
Serogroups ACWY | 80 | 0.02 |
Serogroup B | 40 | 0.01 |
Other serogroups | 16 | 0.00 |
Unknown serogroup | 106 | 0.03 |
Mumps | 694 | 0.21 |
Novel Influenza A virus infections | — | — |
Pertussis | 6,124 | 1.86 |
Plague §§§ | 9 | 0.00 |
Poliomyelitis, paralytic | — | — |
Poliovirus infection, nonparalytic | — | — |
Psittacosis | 8 | 0.00 |
Q fever | ||
Total | 120 | 0.04 |
Acute | 90 | 0.03 |
Chronic | 30 | 0.01 |
Rabies | ||
Animal | 4,457 | 1.35 |
Human | — | — |
Rubella | 6 | 0.00 |
Rubella, congenital syndrome | — | — |
Salmonella Paratyphi infection ¶¶¶ | 75 | 0.02 |
Salmonella Typhi infection **** | 182 | 0.06 |
Salmonellosis (excluding S. Typhi infection and S. Paratyphi infection) †††† | 45,442 | 13.79 |
Severe acute respiratory syndrome-associated coronavirus disease | — | — |
Shiga toxin-producing Escherichia coli (STEC) | 9,922 | 3.01 |
Shigellosis | 9,108 | 2.76 |
Smallpox | — | — |
Spotted fever rickettsiosis | ||
Total | 1,175 | 0.36 |
Confirmed | 64 | 0.02 |
Probable | 1,111 | 0.34 |
Streptococcal toxic shock syndrome | 224 | 0.11 |
Syphilis | ||
Total, all stages §§§§ | 133,933 | 40.65 |
Congenital ¶¶¶¶ | 2,148 | 55.88 |
Primary and secondary | 41,654 | 12.64 |
Tetanus | 17 | 0.01 |
Toxic shock syndrome (other than Streptococcal) | 24 | 0.01 |
Trichinellosis | — | — |
Tuberculosis | 7,174 | 2.18 |
Tularemia | 150 | 0.05 |
Vancomycin-intermediate Staphylococcus aureus | 45 | 0.02 |
Vancomycin-resistant Staphylococcus aureus ***** | 1 | 0.00 |
Varicella morbidity | 2,927 | 1.05 |
Varicella mortality | 1 | 0.00 |
Vibriosis | ||
Total | 1,852 | 0.57 |
Confirmed | 1,133 | 0.35 |
Probable | 719 | 0.22 |
Viral hemorrhagic fevers | ||
Crimean-Congo hemorrhagic fever virus | — | — |
Ebola virus | — | — |
Guanarito virus | — | — |
Junin virus | — | — |
Lassa virus | — | — |
Lujo virus | — | — |
Machupo virus | — | — |
Marburg virus | — | — |
Sabia virus | — | — |
Yellow fever | — | — |
Zika virus | ||
Zika virus disease, congenital ††††† | — | — |
Zika virus disease, non-congenital | 4 | 0.00 |
Zika virus infection, congenital ††††† | — | — |
Zika virus infection, non-congenital | 19 | 0.01 |
- [ Export ]
- [ PDF ]
- [ Next Table ]
- [ Annual Tables ]
- [ Weekly Tables ]